The agreement covers Thailand, Vietnam, Indonesia and Malaysia.
Hamlet Protein said it is looking to expand further in Asia, building on the local network and market knowledge of that distribution player.
The Denmark headquartered company told this publication before that the tie-up with Jebsen & Jessen makes the regulatory side of Asian market development less challenging.
Hamlet Protein has a mix of distribution relationships and local staff operating in China, Vietnam, Philippines and Thailand, supported by its global technical management; it said such a set-upp enables it to understand local market dynamics and translate that into practical applications for feed mills, premixers, integrators and farmers.
It has been investing in Asia in recent months. “We have added local technical and commercial resources to be closer to our customers. We are also working in selected markets on introducing our concepts into the poultry segment, building on years of experience and research in piglet and calf nutrition and health,” said CEO, Erik Visser.
ASF impact
While the Covid-19 pandemic has been affecting the animal protein supply chain across the region, African Swine Fever (ASF) continues to be a challenge for commercial pig producers, said the company.
Large pig farming companies in China are cautiously restocking, it said but Hamlet noted that, in the Philippine, ASF continues to spread within backyard farms on the islands of Luzon and Mindanao.
In Vietnam, 44 of 63 provinces declared themselves ASF free in Q1.
“These are challenging times for our industry. However we have a long-term commitment to producers in Asia and are investing today to strengthen relationships like our partnership with Jebsen & Jessen and build new ones with customers across the region,” added Visser.
Hamlet Protein produces soy-based protein ingredients for young piglet, poultry and cattle feed at two production plants in Denmark and the US.
